Oracea Capsule
Product Images NDC 0299-3822

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oracea (NDC 0299-3822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galderma Laboratories, L.p., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

P56801 0 Production Proof 2249 Page 1

ORACEA 40 mg capsules label showing doxycycline as the active ingredient. The label indicates each capsule contains 30 mg immediate release and 10 mg delayed release beads. The package contains 30 capsules and is RX only. Marketed by Galderma Laboratories, L.P., the label includes storage instructions and cautions to keep out of reach of children.*

FDA Label Image

Oracea-chem-struct (Oracea Chem Struct)

Chemical structure diagram of doxycycline, the active ingredient in ORACEA capsules. The diagram shows the molecular framework including hydroxyl, carbonyl, dimethylamino, and amide groups, and includes a molecule of water (hydrate).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.